论文部分内容阅读
对47例原发性肝癌患者采用皮下泵行双介入治疗,即对肝动脉栓塞化疗和门静脉灌注化疗(栓塞组)、肝动脉门静脉双灌注化疗(化疗组和局部预防组)。临床结果表明:无论在临床症状改善、肿瘤缩小程度、治疗的有效还是延长生存期方面,栓塞组均比化疗组显著,而肝癌切除后局部预防组对肝癌复发的预防比周围预防组(经周围静脉化疗)疗效显著。该方法操作简便,易于掌握,并发症少,提供了一条治疗肝癌的有效途径。
Forty-seven patients with primary liver cancer underwent dual-interventional subcutaneous pump therapy, ie, hepatic artery embolization chemotherapy and portal vein infusion chemotherapy (embolization group), hepatic artery portal vein dual infusion chemotherapy (chemotherapy group and local prevention group). The clinical results showed that the embolization group was significantly more effective than the chemotherapy group in terms of improvement of clinical symptoms, reduction of tumor size, effective treatment, and prolonged survival, while prevention of hepatocellular carcinoma recurrence was more effective in the prevention group than in the surrounding prevention group (after peripheral resection). The effect of intravenous chemotherapy is significant. The method is simple, easy to handle, and has few complications, providing an effective way to treat liver cancer.